Home Cart 0 Sign in  

[ CAS No. 38092-89-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 38092-89-6
Chemical Structure| 38092-89-6
Structure of 38092-89-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 38092-89-6 ]

Related Doc. of [ 38092-89-6 ]

Alternatived Products of [ 38092-89-6 ]

Product Details of [ 38092-89-6 ]

CAS No. :38092-89-6 MDL No. :MFCD06411084
Formula : C20H21ClN2 Boiling Point : -
Linear Structure Formula :- InChI Key :VLXSCTINYKDTKR-UHFFFAOYSA-N
M.W : 324.85 Pubchem ID :31843
Synonyms :
Chemical Name :8-Chloro-11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine

Calculated chemistry of [ 38092-89-6 ]

Physicochemical Properties

Num. heavy atoms : 23
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.35
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 100.38
TPSA : 16.13 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.29 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.61
Log Po/w (XLOGP3) : 4.22
Log Po/w (WLOGP) : 3.98
Log Po/w (MLOGP) : 3.88
Log Po/w (SILICOS-IT) : 5.09
Consensus Log Po/w : 4.16

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.9
Solubility : 0.0041 mg/ml ; 0.0000126 mol/l
Class : Moderately soluble
Log S (Ali) : -4.27
Solubility : 0.0175 mg/ml ; 0.0000538 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -7.05
Solubility : 0.0000292 mg/ml ; 0.0000000899 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.31

Safety of [ 38092-89-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 38092-89-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 38092-89-6 ]
  • Downstream synthetic route of [ 38092-89-6 ]

[ 38092-89-6 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 119770-60-4 ]
  • [ 38092-89-6 ]
YieldReaction ConditionsOperation in experiment
85% at 105 - 110℃; for 4 - 8 h; Example 2Preparation of 8-chloro-6, ll-dihydro-ll-(N-methyl-4-piperidinylidene)-5H-benzo [5,6] cyclohepta [1, 2-b] pyridine (XII)Compound XIII (100 g) prepared as per standard process given in US patent no4,659,716 after azeotropic water removal in toluene instead of drying is heated withboric acid (115 g) in cone, sulfuric acid (415 g) for 4-8 hrs at 105-11Q°C, Reactionmass is poured in chilled water and extracted with ethyl acetate. Solvent is removed toget the title compound as a solid in 85percent yield having assay 99.5percent (OAB, HPLC)
HPLC purity: 95% With boron trifluoride In HF; hexane E.
8-Chloro-11-(1-Methyl-4-Piperidylidene)-6,11-Dihydro-5H-Benzo[5,6]Cyclohepta[1,2-b]Pyridine STR66
Dissolve the title compound of Preparative Example 1D above (59 g, 0.15 mole) in HF (120 mL, 120 g, 6.0 mole) at -35° C. and add BF3 (44.3 g, 0.66 mole) over 1 hour.
Determine completeness of the reaction by thin layer chromatography.
Quench the reaction using ice, water and KOH bringing the solution to a final pH of 10.
Extract the product with toluene and wash with water and brine.
Concentrate the toluene solution to a residue, and dissolve in hot hexane.
Remove the insolubles by filtration and concentrate the filtrate to yield the title compound as an off-white powder. (Yield: 45.7 g (HPLC purity: 95percent), 92percent of theory).
HPLC purity 80% With hydrogenchloride; sodium hydroxide In ice-water; hexane; trifluorormethanesulfonic acid Alternative Step E:
8-Chloro-11-(1-Methyl-4-Piperidylidene)-6,11-Dihydro-5H-Benzo[5,6]Cyclohepta[1,2-b]Pyridine
React the title compound of Preparative Example 1D above (177 g, 0.49 mole) in trifluoromethanesulfonic acid (480 ml, 814.1 g, 5.31 mole) at 90-95° C. for 18 hours under nitrogen.
Determine the completeness of the reaction by thin layer chromatography.
Cool the reaction and quench the reaction with ice-water and adjust the pH to 6 with BaCO3.
Extract the product with CH2 Cl2, and concentrate under reduced pressure to about 1 liter.
Wash with water, and extract the product into 1 N HCl which is treated with 30 g of activated charcoal, and filter through celite.
Adjust the pH of the filtrate to 10 with aqueous NaOH (50percent), extract the product into CH2 Cl2, and remove under reduced pressure to form a residue.
Dissolve the residue in hot hexane, and filter to remove insolubles.
Concentrate the filtrate to yield the title compound as a beige powder. (Yield: 126 g (HPLC purity 80percent), 65percent of theory).
HPLC purity: 95% With boron trifluoride In hexane; hydrogen fluoride E.
8-CHLORO-11-(1-METHYL-4-PIPERIDYLIDENE)-6,11-DIHYDRO-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE STR69
Dissolve the title compound of Preparative Example 1D above (59 g, 0.15 mole) in hydrofluoric acid (120 mL, 120 g, 6.0 mole) at -35° C. and add boron trifluoride (44.3 g, 0.66 mole) over 1 hour.
Determine completeness of the reaction by thin layer chromatography.
Quench the reaction using ice, water and potassium hydroxide bringing the solution to a final pH of 10.
Extract the product with toluene and wash with water and brine.
Concentrate the toluene solution to a residue, and dissolve in hot hexane.
Remove the insolubles by filtration and concentrate the filtrate to yield the title compound as an off-white powder. (Yield: 45.7 g (HPLC purity: 95percent), 92percent of theory).
HPLC purity 80% With hydrogenchloride; sodium hydroxide In (2S)-N-methyl-1-phenylpropan-2-amine hydrate; hexane; trifluorormethanesulfonic acid Alternative Step E:
8-CHLORO-11-(1-METHYL-4-PIPERIDYLIDENE)-6,11-DIHYDRO-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE
React the title compound of Preparative Example 1D above (177 g, 0.49 mole) in trifluoromethanesulfonic acid (480 ml, 814.1 g, 5.31 mole) at 90°-95° C. for 18 hours under nitrogen.
Determine the completeness of the reaction by thin layer chromatography.
Cool the reaction and quench the reaction with ice-water and adjust the pH to 6 with barium carbonate.
Extract the product with methylene chloride, and concentrate under reduced pressure to about 1 liter.
Wash with water, and extract the product into 1N HCl which is treated with 30 g of activated charcoal, and filter through celite.
Adjust the pH of the filtrate to 10 with aqueous sodium hydroxide (50percent), extract the product into methylene chloride, and remove under reduced pressure to form a residue.
Dissolve the residue in hot hexane, and filter to remove insolubles.
Concentrate the filtrate to yield the title compound as a beige powder. (Yield: 126 g (HPLC purity 80percent), 65percent of theory).
HPLC purity: 95% With boron trifluoride In hexane; hydrogen fluoride E.
8-Chloro-11-(1-Methyl-4-Piperidylidene)-6,11-Dihydro-5H-Benzo[5,6]Cyclohepta[1,2-b]Pyridine STR67
Dissolve the title compound of Preparative Example 1D above (59 g, 0.15 mole) in hydrofluoric acid (120 mL, 120 g, 6.0 mole) at -35° C. and add boron trifluoride (44.3 g, 0.66 mole) over 1 hour.
Determine completeness of the reaction by thin layer chromatography.
Quench the reaction using ice, water and potassium hydroxide bringing the solution to a final pH of 10.
Extract the product with toluene and wash with water and brine.
Concentrate the toluene solution to a residue, and dissolve in hot hexane.
Remove the insolubles by filtration and concentrate the filtrate to yield the title compound as an off-white powder. (Yield: 45.7 g (HPLC purity: 95percent), 92percent of theory).
HPLC purity 80% With hydrogenchloride; sodium hydroxide In ice-water; hexane; trifluorormethanesulfonic acid Alternative Step E:
8-CHLORO-11-(1-METHYL-4-PIPERIDYLIDENE)-6,11-DIHYDRO-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE
React the title compound of Preparative Example 1D above (177 g, 0.49 mole) in trifluoromethanesulfonic acid (480 ml, 814.1 g, 5.31 mole) at 90°-95° C. for 18 hours under nitrogen.
Determine the completeness of the reaction by thin layer chromatography.
Cool the reaction and quench the reaction with ice-water and adjust the pH to 6 with barium carbonate.
Extract the product with CH2 Cl2, and concentrate under reduced pressure to about 1 liter.
Wash with water, and extract the product into 1N HCl which is treated with 30 g of activated charcoal, and filter through celite.
Adjust the pH of the filtrate to 10 with aqueous NaOH (50percent), extract the product into CH2 Cl2, and remove under reduced pressure to form a residue.
Dissolve the residue in hot hexane, and filter to remove insolubles.
Concentrate the filtrate to yield the title compound as a beige powder. (Yield: 126 g (HPLC purity 80percent), 65percent of theory).
HPLC purity 80% With hydrogenchloride; sodium hydroxide In ice-water; hexane; trifluorormethanesulfonic acid Alternative Step E:
8-Chloro-11-(1-Methyl-4-Piperidylidene)-6,11-Dihydro-5H-Benzo[5,6]Cyclohepta[1,2-b]Pyridine
React the title compound of Preparative Example 1D above (177 g, 0.49 mole) in trifluoromethanesulfonic acid (480 ml, 814.1 g, 5.31 mole) at 90°-95° C. for 18 hours under nitrogen.
Determine the completeness of the reaction by thin layer chromatography.
Cool the reaction and quench the reaction with ice-water and adjust the pH to 6 with barium carbonate.
Extract the product with methylene chloride, and concentrate under reduced pressure to about 1. liter.
Wash with water, and extract the product into 1N HCl which is treated with 30 g of activated charcoal, and filter through celite.
Adjust the pH of the filtrate to 10 with aqueous sodium hydroxide (50percent), extract the product into methylene chloride, and remove under reduced pressure to form a residue.
Dissolve the residue in hot hexane, and filter to remove insolubles.
Concentrate the filtrate to yield the title compound as a beige powder. (Yield: 126 g (HPLC purity 80percent), 65percent of theory).
HPLC purity 80% With hydrogenchloride; sodium hydroxide In ice-water; hexane; trifluorormethanesulfonic acid Alternative Step E:
8-CHLORO-11-(1-METHYL-4-PIPERIDYLIDENE)-6,11-DIHYDRO-5H-BENZO[5,6]CYCLOHEPTA [1,2-b]PYRIDINE
React the title compound of Preparative Example 1D above (177 g, 0.49 mole) in trifluoromethanesulfonic acid (480 ml, 814.1 g, 5.31 mole) at 90°-95° C. for 18 hours under nitrogen.
Determine the completeness of the reaction by thin layer chromatography.
Cool the reaction and quench the reaction with ice-water and adjust the pH to 6 with BaCO3.
Extract the product with CH2 Cl2, and concentrate under reduced pressure to about 1 liter.
Wash with water, and extract the product into 1N HCl which is treated with 30 g of activated charcoal, and filter through celite.
Adjust the pH of the filtrate to 10 with aqueous NaOH (50percent), extract the product into CH2 Cl2, and remove under reduced pressure to form a residue.
Dissolve the residue in hot hexane, and filter to remove insolubles.
Concentrate the filtrate to yield the title compound as a beige powder. (Yield: 126 g (HPLC purity 80percent), 65percent of theory).
HPLC purity: 95% With boron trifluoride In hexane; hydrogen fluoride E.
8-CHLORO-11-(1-METHYL-4-PIPERIDYLIDENE)-6.11-DIHYDRO-5H-BENZO[5.6]CYCLOHEPTA[1,2-b]PYRIDINE STR97
Dissolve the title compound of Preparative Example 1D above (59 g, 0.15 mole) in hydrofluoric acid (120 mL, 120 g, 6.0 mole) at -35° C. and add boron trifluoride (44.3 g, 0.66 mole) over 1 hour.
Determine completeness of the reaction by thin layer chromatography.
Quench the reaction using ice, water and KOH bringing the solution to a final pH of 10.
Extract the product with toluene and wash with water and brine.
Concentrate the toluene solution to a residue, and dissolve in hot hexane.
Remove the insolubles by filtration and concentrate the filtrate to yield the title compound as an off-white powder. (Yield: 45.7 g (HPLC purity: 95percent), 92percent of theory).
HPLC purity: 95% With boron trifluoride In HF; hexane E.
8-CHLORO-11-(1-METHYL-4-PIPERIDYLIDENE)-6,11-DIHYDRO-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE STR66
Dissolve the title compound of Preparative Example 1D above (59 g, 0.15 mole) in HF (120 mL, 120 g, 6.0 mole) at -35° C. and add BF3 (44.3 g, 0.66 mole) over 1 hour.
Determine completeness of the reaction by thin layer chromatography.
Quench the reaction using ice, water and KOH bringing the solution to a final pH of 10.
Extract the product with toluene and wash with water and brine.
Concentrate the toluene solution to a residue, and dissolve in hot hexane.
Remove the insolubles by filtration and concentrate the filtrate to yield the title compound as an off-white powder. (Yield: 45.7 g (HPLC purity: 95percent), 92percent of theory).

Reference: [1] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[2] Patent: WO2006/6184, 2006, A2, . Location in patent: Page/Page column 17
[3] Patent: US6075025, 2000, A,
[4] Patent: US6075025, 2000, A,
[5] Patent: US5422351, 1995, A,
[6] Patent: US5422351, 1995, A,
[7] Patent: US5661152, 1997, A,
[8] Patent: US5719148, 1998, A,
[9] Patent: US5661152, 1997, A,
[10] Patent: US5721236, 1998, A,
[11] Patent: US5719148, 1998, A,
[12] Patent: US5721236, 1998, A,
  • 2
  • [ 38089-93-9 ]
  • [ 38092-89-6 ]
YieldReaction ConditionsOperation in experiment
80% at 35 - 45℃; for 2 - 3 h; A mixture of L L-(N-METHYL-4-PIPERIDINYL)-11-HYDROXY-8-CHLORO-6, 11-DIHYDRO-5H- BENZO (5,6) cyclohepta (1,2-b) pyridine (carbinol) of formula IV (1.0 kg, 0.0029 mole) and concentrated sulphuric acid (3.68 kg, 0.0375 mole) is stirred at 35 to 45°C for 2 to 3 hrs. the reaction mixture is poured in chilled water and the product (olefin) is extracted in ethyl acetate at 8-9 pH. The organic phase is dried over anhydrous sodium sulphate and solvent is removed, The residue is crystallized in hexane to give 0.8 kg of olefin of formula V (80percent) with a purity of >98percent (ODB, HPLC).
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 8, p. 2701 - 2704
[2] Patent: WO2004/80997, 2004, A1, . Location in patent: Page 9
[3] Patent: WO2006/6184, 2006, A2, . Location in patent: Page/Page column 16-17
  • 3
  • [ 119770-60-4 ]
  • [ 119770-61-5 ]
  • [ 38092-89-6 ]
Reference: [1] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
  • 4
  • [ 32998-95-1 ]
  • [ 38092-89-6 ]
Reference: [1] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[2] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[3] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[4] Journal of Medicinal Chemistry, 1991, vol. 34, # 1, p. 457 - 461
  • 5
  • [ 31255-57-9 ]
  • [ 38092-89-6 ]
Reference: [1] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[2] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[3] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[4] Journal of Medicinal Chemistry, 1991, vol. 34, # 1, p. 457 - 461
  • 6
  • [ 107285-30-3 ]
  • [ 38092-89-6 ]
Reference: [1] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[2] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[3] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[4] Journal of Medicinal Chemistry, 1991, vol. 34, # 1, p. 457 - 461
  • 7
  • [ 63463-36-5 ]
  • [ 38092-89-6 ]
Reference: [1] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[2] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[3] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[4] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 8, p. 2701 - 2704
  • 8
  • [ 20970-75-6 ]
  • [ 38092-89-6 ]
Reference: [1] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[2] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[3] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
  • 9
  • [ 100643-71-8 ]
  • [ 74-88-4 ]
  • [ 38092-89-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 22, p. 9473 - 9479
  • 10
  • [ 75-75-2 ]
  • [ 119770-60-4 ]
  • [ 119770-62-6 ]
  • [ 38092-89-6 ]
Reference: [1] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
  • 11
  • [ 130642-50-1 ]
  • [ 38092-89-6 ]
Reference: [1] Journal of Medicinal Chemistry, 1991, vol. 34, # 1, p. 457 - 461
  • 12
  • [ 620-20-2 ]
  • [ 38092-89-6 ]
Reference: [1] Journal of Medicinal Chemistry, 1991, vol. 34, # 1, p. 457 - 461
  • 13
  • [ 31251-41-9 ]
  • [ 38092-89-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 8, p. 2701 - 2704
  • 14
  • [ 38092-89-6 ]
  • [ 100643-71-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1991, vol. 34, # 1, p. 457 - 461
[2] Patent: US5089496, 1992, A,
[3] Patent: US4826853, 1989, A,
[4] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 8, p. 2701 - 2704
  • 15
  • [ 541-41-3 ]
  • [ 38092-89-6 ]
  • [ 79794-75-5 ]
YieldReaction ConditionsOperation in experiment
90% With N-ethyl-N,N-diisopropylamine In toluene at 60 - 75℃; for 1 - 2 h; To a mixture of 8-CHLORO-6, 11-DIHYDRO-11-(N-METHYL-4-PIPERIDINYLIDENE)-5H- benzo (5, 6) cyclohepta (1,2-b) pyridine (olefin) of formula V (1. 0 KG, 0. 0031 mole) and diisopropylethylamine (0. 074 KG, 0.00057 mole) in TOLUENE (6 Lt) under nitrogen atmosphere, ETHYLCHLOROFORMATE (0. 775 kg, 0.0071 mole) is added slowly at 60 to 65°C and stirred for 1 to 2 hrs, at 70-75°C. Reaction mixture cooled to room temperature and water (5. 0 Lt) is added. The mixture is adjusted to 5. 0-5.5 pH with hydrochloric acid. The organic phase is washed with water and the solvent is removed. The residue is purified in isopropyl ether followed by CRYSTALLIZATION in acetonitrile to get 0. 9 kg loratadine (90percent) with a purity of >99percent (ODB, HPLC).
73%
Stage #1: With N-ethyl-N,N-diisopropylamine In toluene at 60 - 75℃; for 1 - 2 h;
Stage #2: With hydrogenchloride In water; toluene
Step 10; Preparation of Loratadine (I)To the above toluene layer from example 16, containing compound XII (-93 gm, 0.29 mole) is added di isopropyl ethylamine (11.1 gm, 0.09 mole) under nitrogen atmosphere followed by slow addition of ethyl chloroformate (82 gm, 0.71 mole) at 60-65°C and stirred for 1-2 hrs at 70-75°C. Reaction mixture is cooled to room temperature and water (600 ml) is added. The mixture is adjusted to pH 5.0 -5.5 with hydrochloric acid. The organic phase is washed with water and the solvent is removed to get residue as crude Loratadine .The crude Loratadine is purified in isopropyl ether followed by crystallization in acetonitrile to get 81.5 gm Loratadine of formula I (73percent) with a purity of >99.4percent (ODB,HPLC).
HPLC purity 97.4% With N-ethyl-N,N-diisopropylamine In toluene; acetonitrile F.
8-CHLORO-11-(1-ETHOXYCARBONYL-4-PIPERIDYLIDENE)-6,11-DIHYDRO-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE STR70
Dissolve the title compound of Preparative Example 1E above (45.6 g, 0.141 mole) in toluene (320 mL) at 80° C. and to it gradually add ethyl chloroformate (40.4 mL, 45.9 g, 0.423 mole).
Following complete addition, maintain the temperature at 80° C. for 1 hour, then add diisopropylethylamine (2.7 mL, 2.00 g, 0.016 mole) and additional ethyl chloroformate (4.1 mL, 4.65 g, 0.0429 mole).
Monitor completeness of the reaction by thin layer chromatography.
Upon completion, cool the reaction mixture to ambient temperature, and wash the toluene solution with water.
Concentrate the organic layer to a residue and dissolve in hot acetonitrile (320 mL).
Decolorize the solution with 14 g of activated charcoal.
Remove the activated charcoal by filtration and concentrate the filtrate to a crystalline slurry.
Cool the mixture to 0°-5° C., and isolate the product by filtration.
Wash with cold acetonitrile and dry the product at below 70° C. to yield the title compound. (Yield: 42.4 g (HPLC purity 97.4percent), 80percent of theory).
HPLC purity 97.4% With N-ethyl-N,N-diisopropylamine In toluene; acetonitrile F.
8-Chloro-11-(1-Ethoxycarbonyl-4-Piperidylidene)6,11-Dihydro-5H-Benzo[5,6]Cyclohepta[1,2-b]Pyridine STR68
Dissolve the title compound of Preparative Example 1E above (45.6 g, 0.141 mole) in toluene (320 mL) at 80° C. and to it gradually add ethyl chloroformate (40.4 mL, 45.9 g, 0.423 mole).
Following complete addition, maintain the temperature at 80° C. for 1 hour, then add diisopropylethylamine (2.7 mL, 2.00 g, 0.016 mole) and additional ethyl chloroformate (4.1 mL, 4.65 g, 0.0429 mole).
Monitor completeness of the reaction by thin layer chromatography.
Upon completion, cool the reaction mixture to ambient temperature, and wash the toluene solution with water.
Concentrate the organic layer to a residue and dissolve in hot acetonitrile (320 mL).
Decolorize the solution with 14 g of activated charcoal.
Remove the activated charcoal by filtration and concentrate the filtrate to a crystalline slurry.
Cool the mixture to 0°-5° C., and isolate the product by filtration.
Wash with cold acetonitrile and dry the product at below 70° C. to yield the title compound, (Yield: 42.4 g (HPLC purity 97.4percent), 80percent of theory).
HPLC purity 97.4% With N-ethyl-N,N-diisopropylamine In toluene; acetonitrile F.
8-Chloro-11-(1-Ethoxycarbonyl-4-Piperidylidene)-6,11-Dihydro-5H-Benzo[5,6]Cyclohepta[1,2-b]Pyridine STR81
Dissolve the title compound of Preparative Example 1E above (45.6 g, 0.141 mole) in toluene (320 mL) at 80° C. and to it gradually add ethyl chloroformate (40.4 mL, 45.9 g, 0.423 mole).
Following complete addition, maintain the temperature at 80° C. for 1 hour, then add diisopropylethylamine (2.7 mL, 2.00 g, 0.016 mole) and additional ethyl chloroformate (4.1 mL, 4.65 g, 0.0429 mole).
Monitor completeness of the reaction by thin layer chromatography.
Upon completion, cool the reaction mixture to ambient temperature, and wash the toluene solution, with water.
Concentrate the organic layer to a residue and dissolve in hot acetonitrile (320 mL).
Decolorize the solution with 14 g of activated charcoal.
Remove the activated charcoal by filtration and concentrate the filtrate to a crystalline slurry.
Cool the mixture to 0°-5° C., and isolate the product by filtration.
Wash with cold acetonitrile and dry the product at below 70° C. to yield the title compound. (Yield: 42.4 g (HPLC purity 97.4percent), 80percent of theory).
HPLC purity 97.4% With N-ethyl-N,N-diisopropylamine In toluene; acetonitrile F.
8-CHLORO-11-(1-ETHOXYCARBONYL-4-PIPERIDYLIDENE)-6,11-DIHYDRO-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE STR98
Dissolve the title compound of Preparative Example 1E above (45.6 g, 0.141 mole) in toluene (320 mL) at 80° C. and to it gradually add ethyl chloroformate (40.4 mL, 45.9 g, 0.423 mole).
Following complete addition, maintain the temperature at 80° C. for 1 hour, then add diisopropylethylamine (2.7 mL, 2.00 g, 0.016 mole) and additional ethyl chloroformate (4.1 mL, 4.65 g, 0.0429 mole).
Monitor completeness of the reaction by thin layer chromatography.
Upon completion, cool the reaction mixture to ambient temperature, and wash the toluene solution with water.
Concentrate the organic layer to a residue and dissolve in hot acetonitrile (320 mL).
Decolorize the solution with 14 g of activated charcoal.
Remove the activated charcoal by filtration and concentrate the filtrate to a crystalline slurry.
Cool the mixture to 0°-5° C., and isolate the product by filtration.
Wash with cold acetonitrile and dry the product at below 70° C. to yield the title compound. (Yield: 42.4 g (HPLC purity 97.4percent), 80percent of theory).

Reference: [1] Patent: WO2004/80997, 2004, A1, . Location in patent: Page 9
[2] Patent: WO2006/6184, 2006, A2, . Location in patent: Page/Page column 17
[3] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 8, p. 2701 - 2704
[4] Arzneimittel-Forschung/Drug Research, 1986, vol. 36, # 9, p. 1311 - 1314
[5] Journal of Medicinal Chemistry, 1991, vol. 34, # 1, p. 457 - 461
[6] Journal of Organic Chemistry, 1989, vol. 54, # 9, p. 2242 - 2244
[7] Patent: US5422351, 1995, A,
[8] Patent: US5661152, 1997, A,
[9] Patent: US5700806, 1997, A,
[10] Patent: US5719148, 1998, A,
[11] Patent: US2008/194823, 2008, A1, . Location in patent: Page/Page column 4
[12] Patent: US2008/194823, 2008, A1, . Location in patent: Page/Page column 5
[13] Patent: US2008/287481, 2008, A1, . Location in patent: Page/Page column 4-5
  • 16
  • [ 541-41-3 ]
  • [ 7087-68-5 ]
  • [ 38092-89-6 ]
  • [ 79794-75-5 ]
Reference: [1] Patent: US6075025, 2000, A,
[2] Patent: US5721236, 1998, A,
  • 17
  • [ 541-41-3 ]
  • [ 7440-44-0 ]
  • [ 38092-89-6 ]
  • [ 79794-75-5 ]
Reference: [1] Patent: US4863931, 1989, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 38092-89-6 ]

Alkenes

Chemical Structure| 98420-89-4

[ 98420-89-4 ]

4-Chloro-2-vinylpyridine

Similarity: 0.60

Chemical Structure| 69257-04-1

[ 69257-04-1 ]

(2S,4S,5R)-1-Benzyl-2-((R)-hydroxy(quinolin-4-yl)methyl)-5-vinylquinuclidin-1-ium chloride

Similarity: 0.60

Chemical Structure| 3505-38-2

[ 3505-38-2 ]

Carbinoxamine Maleate

Similarity: 0.60

Chemical Structure| 142569-70-8

[ 142569-70-8 ]

(S)-1-(3-(2-(7-Chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propan-1-ol

Similarity: 0.60

Chemical Structure| 74173-48-1

[ 74173-48-1 ]

4-Methyl-4'-vinyl-2,2'-bipyridine

Similarity: 0.59

Chlorides

Chemical Structure| 5969-83-5

[ 5969-83-5 ]

2-(4-Chlorophenyl)pyridine

Similarity: 0.82

Chemical Structure| 86-98-6

[ 86-98-6 ]

4,7-Dichloroquinoline

Similarity: 0.74

Chemical Structure| 611-35-8

[ 611-35-8 ]

4-Chloroquinoline

Similarity: 0.72

Chemical Structure| 142404-69-1

[ 142404-69-1 ]

2-(Chloro(4-chlorophenyl)methyl)pyridine

Similarity: 0.71

Chemical Structure| 122368-54-1

[ 122368-54-1 ]

2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine

Similarity: 0.70

Related Parent Nucleus of
[ 38092-89-6 ]

Aliphatic Heterocycles

Chemical Structure| 533-37-9

[ 533-37-9 ]

6,7-Dihydro-5H-cyclopenta[b]pyridine

Similarity: 0.61

Chemical Structure| 99329-53-0

[ 99329-53-0 ]

4-(3-Chlorophenyl)piperidine

Similarity: 0.59

Chemical Structure| 6652-06-8

[ 6652-06-8 ]

4-(4-Chlorophenyl)piperidine hydrochloride

Similarity: 0.59

Chemical Structure| 99329-70-1

[ 99329-70-1 ]

4-(3-Chlorophenyl)piperidine hydrochloride

Similarity: 0.58

Chemical Structure| 52423-70-8

[ 52423-70-8 ]

2-(3-(4-Chlorophenyl)pyrrolidin-3-yl)ethanol

Similarity: 0.57

Piperidines

Chemical Structure| 201594-84-5

[ 201594-84-5 ]

(S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine

Similarity: 0.70

Chemical Structure| 122368-54-1

[ 122368-54-1 ]

2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine

Similarity: 0.70

Chemical Structure| 690261-73-5

[ 690261-73-5 ]

3-(Piperidin-4-yl)pyridine hydrochloride

Similarity: 0.65

Chemical Structure| 40864-10-6

[ 40864-10-6 ]

2-(Piperidin-3-yl)pyridine

Similarity: 0.65

Chemical Structure| 352220-15-6

[ 352220-15-6 ]

3-(Piperidin-2-yl)pyridine hydrochloride

Similarity: 0.63